id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0033-0004,FDA,FDA-2011-N-0033,Oral Dosage Form New Animal Drugs; Change of Sponsor,Rule,,2011-07-08T00:00:00Z,2011,7,,,2011-07-08T16:56:38Z,,0,1,0900006480ebcd27
FDA-2011-N-0033-0003,FDA,FDA-2011-N-0033,Withdrawal of Approval of New Animal Drug Applications: Phenylbutazone; Pyrantel; Tylosin; Sulfamethazine; Correction,Notice,NCR-Notice of Correction,2011-04-22T04:00:00Z,2011,4,2011-04-22T04:00:00Z,,2011-04-22T12:59:00Z,2011-09778,0,0,0900006480c358e2
FDA-2011-N-0033-0002,FDA,FDA-2011-N-0033,See FDA-2011-N-0003-0006,Supporting & Related Material,,2011-03-23T00:00:00Z,2011,3,,,2011-03-25T15:15:29Z,,0,1,0900006480c0ec37
FDA-2011-N-0033-0001,FDA,FDA-2011-N-0033,Withdrawals of Approvals of New Animal Drug Applications: Phenylbutazone; Pyrantel; Tylosin; Sulfamethazine,Notice,NWL-Notice of Withdrawl,2011-03-02T05:00:00Z,2011,3,,,2011-03-02T17:30:00Z,2011-04545,0,0,0900006480bfcc0b